🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

MATTERHORN is durvalumab-based not pembro. Are slides not being reviewed before primetime? 🤦‍♂️ #ASCO25

Censoring alert in MATTERHORN (Durva+FLOT vs Placebo+FLOT) 64.8% censored in the durvalumab arm vs 54.0% in placebo ➕ Most were censored as event-free at cut-off, not due to long-term follow-up ⏳ Curves flatten after 24m — but with <20 pts at risk = unstable tails ❗ Median

#ASCO2025 day 4 📸🤳with the genius Matteo Lambertini, MD PhD

From the legend - Testicular germ cell tumor management by Dr Lawrence Einhorn #ASCO2025

What is the role of PETCT in postchemotherapy seminoma? by Lucia Nappi 🎯FDG PET highly sensitive 🎯NPV 90-100% even for residual lesions >=3 cm 🎯LOW PPV ~ 23% #ASCO2025

Pitfalls during management of mNSGCTs by Dr Lawrence Einhorn Indiana University 🎯 Understand the false positives and minimal persistence of TMs post therapy 🎯No need of CBC on day 8 and day 15 🎯Long-term surveillance for late relapses #ASCO2025 Testicular Cancer UK Testicular Cancer

What do you do when multiple postchenotherapy residual disease in NSGCT? By Lucia Nappi 🎯GET RPLND FIRST 🎯RPLN histology will decide further management 🎯if Fibrosis —> 80% concordance with extra RP lesions, SURVEILLANCE can be considered 🎯Viable or teratoma —> 40%

Role of post-resection adjuvant chemotherapy? Lucia Nappi #ASCO2025

Because before anything else, every oncologist is a patient advocate. For equity. For access. For every life. 📍#ASCO25 — The place to conquer cancer, together. #CancerCare #Oncology #PatientRights #Advocacy #ConquerCancer @oncoalert ASCO Conquer Cancer, the ASCO Foundation Robin Zon, MD, FACP, FASCO

Long-term survivorship issues in testicular cancers #ASCO2025

One of the best sessions from #ASCO2025

Fan moment. With Dr Lawrence Einhorn 🙇 at #ASCO25 Indiana University Department of Urology IU Simon Comprehensive Cancer Center Amit Joshi gaganprakash Amandeep Arora

Need Pragmatic trials and Real-World Evidence. Excellent talk Timothée Olivier, MD Dr Amol Akhade #ASCO25

#ASCO25 Was humbled to see a patient approach me on the heels of our presentation yesterday & sharing his experience of achieving CR with EV-P & maintaining it despite on a break from EV for neuropathy. He thanked us for validating his personal experience & providing reassurance

Ok the update to the SOFT and TEXT trial is critically important for the general onc community. Please do not put young women on tamoxifen alone as a default. Ovarian suppression and aromatase inhibitor (not tam) is lifesaving. It’s more important than chemo for many #ASCO25

Another abstract from our group on impact of size of NGS panels in management of NSCLC. #ASCO25 M | O | C Cancer Care & Research Centre

This is Air India. It resets my original booking and my seat selection and then asks for more money to get seat of my choice. Air India DGCA Ram Mohan Naidu Kinjarapu Rajesh Dogra 🇮🇳